Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Chunlai Yin, Qiuju Han, Dongqing Xu, Bingqing Zheng, Xuemei Zhao & Jian Zhang. (2019) SALL4-mediated upregulation of exosomal miR-146a-5p drives T-cell exhaustion by M2 tumor-associated macrophages in HCC. OncoImmunology 8:7.
Read now
Read now
Antonio Gnoni, Daniele Santini, Mario Scartozzi, Antonio Russo, Antonella Licchetta, Vincenzo Palmieri, Luigi Lupo, Luca Faloppi, Giuseppe Palasciano, Vincenzo Memeo, Gioacchino Angarano, Oronzo Brunetti, Attilio Guarini, Salvatore Pisconti, Vito Lorusso & Nicola Silvestris. (2015) Hepatocellular carcinoma treatment over sorafenib: epigenetics, microRNAs and microenvironment. Is there a light at the end of the tunnel?. Expert Opinion on Therapeutic Targets 19:12, pages 1623-1635.
Read now
Read now
Eman A.E. Badr, Tarek E. Korah, Ashraf Abdel Ghani, Sawsan El-Sayed & Safaa Badr. (2014) Role of serum glypican-3 in the diagnosis and differentiation of small hepatocellular carcinoma from hepatitis-C virus cirrhosis. Alexandria Journal of Medicine 50:3, pages 221-226.
Read now
Read now
Articles from other publishers (45)
Hongyu Zheng, Xueqiang Peng, Shuo Yang, Xinyu Li, Mingyao Huang, Shibo Wei, Sheng Zhang, Guangpeng He, Jiaxing Liu, Qing Fan, Liang Yang & Hangyu Li. (2023) Targeting tumor-associated macrophages in hepatocellular carcinoma: biology, strategy, and immunotherapy. Cell Death Discovery 9:1.
Crossref
Crossref
Bugao Guan, Hongbo Li, Jian Yao, Jinbao Guo, Fei Yu, Guangrun Li, Benhai Wan, Jun Ma, Desong Huang, Lu Sun & Yan Chen. (2022)
CCL3‐CCR5
axis promotes cell migration and invasion of colon adenocarcinoma via Akt signaling pathway
. Environmental Toxicology 38:1, pages 172-184.
Crossref
Crossref
Arshi Khanam & Shyam Kottilil. (2022) New Therapeutics for HCC: Does Tumor Immune Microenvironment Matter?. International Journal of Molecular Sciences 24:1, pages 437.
Crossref
Crossref
Sandra Dios-Barbeito, Raúl González, Miryam Cadenas, Lisander F. García, Victor M. Victor, Francisco J. Padillo & Jordi Muntané. (2022) Impact of nitric oxide in liver cancer microenvironment. Nitric Oxide 128, pages 1-11.
Crossref
Crossref
Jun Liu, Jinglin Mi, Shiqian Liu, Haiqiang Chen & Li Jiang. (2022)
PSMB5
overexpression is correlated with tumor proliferation and poor prognosis in hepatocellular carcinoma
. FEBS Open Bio 12:11, pages 2025-2041.
Crossref
Crossref
Gauri Deb, Alexander Cicala, Athanasios Papadas & Fotis Asimakopoulos. (2022) Matrix proteoglycans in tumor inflammation and immunity. American Journal of Physiology-Cell Physiology 323:3, pages C678-C693.
Crossref
Crossref
Hai-fen Ma, Peng Shu, Xiao-hai Shi, Min Wang & Mao-fen Jiang. (2022) Identification of miR-4510 as a metastasis suppressor of gastric cancer through regulation of tumor microenvironment via targeting GPC3. Clinical & Experimental Metastasis 39:2, pages 363-374.
Crossref
Crossref
Blanca Cucarull, Anna Tutusaus, Patricia Rider, Tania Hernáez-Alsina, Carlos Cuño, Pablo García de Frutos, Anna Colell, Montserrat Marí & Albert Morales. (2022) Hepatocellular Carcinoma: Molecular Pathogenesis and Therapeutic Advances. Cancers 14:3, pages 621.
Crossref
Crossref
Zhuqing Li & Kaitlin M. Bratlie. (2021) The Influence of Polysaccharides‐Based Material on Macrophage Phenotypes. Macromolecular Bioscience 21:8, pages 2100031.
Crossref
Crossref
Isabel Theresa Schobert & Lynn Jeanette Savic. (2021) Current Trends in Non-Invasive Imaging of Interactions in the Liver Tumor Microenvironment Mediated by Tumor Metabolism. Cancers 13:15, pages 3645.
Crossref
Crossref
Shao-Li Huang, Yu-Ming Wang, Quan-Yue Wang, Guang-Gui Feng, Fu-Qing Wu, Liu-Ming Yang, Xi-He Zhang & Hong-Wu Xin. (2021) Mechanisms and Clinical Trials of Hepatocellular Carcinoma Immunotherapy. Frontiers in Genetics 12.
Crossref
Crossref
Lin Yu, Xi Yang, Nan Huang, Meng Wu, Heng Sun, Qilin He, Qiaoli Lang, Xiangang Zou, Zuohua Liu, Jianhua Wang & Liangpeng Ge. (2020) Generation of fully human anti-GPC3 antibodies with high-affinity recognition of GPC3 positive tumors. Investigational New Drugs 39:3, pages 615-626.
Crossref
Crossref
Kaixin Du, Yulu Li, Juan Liu, Wei Chen, Zhizhong Wei, Yong Luo, Huisi Liu, Yonghe Qi, Fengchao Wang & Jianhua Sui. (2021) A bispecific antibody targeting GPC3 and CD47 induced enhanced antitumor efficacy against dual antigen-expressing HCC. Molecular Therapy 29:4, pages 1572-1584.
Crossref
Crossref
Gao Liu, Zhang-Fu Yang, Pei-Yun Zhou, Cheng Zhou, Ruo-Yu Guan, Bao-Ye Sun, Jia Fan, Jian Zhou, Yong Yi & Shuang-Jian Qiu. (2020) ROR-α-1 inhibits the proliferation, invasion, and migration of hepatocellular carcinoma MHCC97H via downregulation of chemokine CXCL5. Cytokine 129, pages 155004.
Crossref
Crossref
Lili Chen, Qianfei Zhang, Chang Yu, Fang Wang & Xiaoni Kong. (2020) Functional roles of CCL5/RANTES in liver disease. Liver Research 4:1, pages 28-34.
Crossref
Crossref
Mushtaq Ahmed, Shyamala Thirunavukkarasu, Bruce A. Rosa, Kimberly A. Thomas, Shibali Das, Javier Rangel-MorenoLan LuSmriti MehraStanley Kimbung Mbandi, Larissa B. ThackrayMichael S. DiamondKenneth M. Murphy, Terry Means, John MartinDeepak Kaushal, Thomas J. Scriba, Makedonka Mitreva & Shabaana A. Khader. (2020) Immune correlates of tuberculosis disease and risk translate across species. Science Translational Medicine 12:528.
Crossref
Crossref
Zhiqiang Tian, Xiaojuan Hou, Wenting Liu, Zhipeng Han & Lixin Wei. (2019) Macrophages and hepatocellular carcinoma. Cell & Bioscience 9:1.
Crossref
Crossref
Sukhneeraj P. Kaur & Brian S. Cummings. (2019) Role of glypicans in regulation of the tumor microenvironment and cancer progression. Biochemical Pharmacology 168, pages 108-118.
Crossref
Crossref
Chris John Weston, Henning Wolfgang Zimmermann & David H. Adams. (2019) The Role of Myeloid-Derived Cells in the Progression of Liver Disease. Frontiers in Immunology 10.
Crossref
Crossref
Zi Yin, Tingting Ma, Ye Lin, Xin Lu, Chuanzhao Zhang, Sheng Chen & Zhixiang Jian. (2018)
Retracted
: IL‐6/STAT3 pathway intermediates M1/M2 macrophage polarization during the development of hepatocellular carcinoma
. Journal of Cellular Biochemistry 119:11, pages 9419-9432.
Crossref
Crossref
H. Degroote, A. Van Dierendonck, A. Geerts, H. Van Vlierberghe & L. Devisscher. (2018) Preclinical and Clinical Therapeutic Strategies Affecting Tumor-Associated Macrophages in Hepatocellular Carcinoma. Journal of Immunology Research 2018, pages 1-9.
Crossref
Crossref
Mikiko Nakamura, Chao Xu, Cheikh Diack, Norihisa Ohishi, Ruey‐min Lee, Satofumi Iida, Takehiko Kawanishi, Toshihiko Ohtomo, Ghassan K. Abou‐Alfa & Ya‐Chi Chen. (2018) Time‐to‐event modelling of effect of codrituzumab on overall survival in patients with hepatocellular carcinoma. British Journal of Clinical Pharmacology 84:5, pages 944-951.
Crossref
Crossref
Fubo Zhou, Wenting Shang, Xiaoling Yu & Jie Tian. (2018) Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment. Medicinal Research Reviews 38:2, pages 741-767.
Crossref
Crossref
Gong Chen, Ya-Chi Chen, Bernhard Reis, Anton Belousov, Lori Jukofsky, Christine Rossin, Axel Muehlig, Chao Xu, Laurent Essioux, Toshihiko Ohtomo, Laura Di Laurenzio, Oscar Puig & Ray Lee. (2018) Combining expression of GPC3 in tumors and CD16 on NK cells from peripheral blood to identify patients responding to codrituzumab. Oncotarget 9:12, pages 10436-10444.
Crossref
Crossref
Arthur ZimmermannArthur Zimmermann. 2017. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract
121
149
.
Arthur ZimmermannArthur Zimmermann. 2017. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract
65
90
.
Ghassan K. Abou-Alfa, Oscar Puig, Bruno Daniele, Masatoshi Kudo, Philippe Merle, Joong-Won Park, Paul Ross, Jean-Marie Peron, Oliver Ebert, Stephen Chan, Tung Ping Poon, Massimo Colombo, Takuji Okusaka, Baek-Yeol Ryoo, Beatriz Minguez, Takayoshi Tanaka, Toshihiko Ohtomo, Stacey Ukrainskyj, Frederic Boisserie, Olga Rutman, Ya-Chi Chen, Chao Xu, Eliezer Shochat, Lori Jukofsky, Bernhard Reis, Gong Chen, Laura Di Laurenzio, Ray Lee & Chia-Jui Yen. (2016) Randomized phase II placebo controlled study of codrituzumab in previously treated patients with advanced hepatocellular carcinoma. Journal of Hepatology 65:2, pages 289-295.
Crossref
Crossref
Arthur ZimmermannArthur Zimmermann. 2016. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract
1
29
.
Arthur ZimmermannArthur Zimmermann. 2016. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract
1
27
.
Yi Li, Yuhuan Zheng, Tianshu Li, Qiang Wang, Jianfei Qian, Yong Lu, Mingjun Zhang, Enguang Bi, Maojie Yang, Frederic Reu, Qing Yi & Zhen Cai. (2015) Chemokines CCL2, 3, 14 stimulate macrophage bone marrow homing, proliferation, and polarization in multiple myeloma. Oncotarget 6:27, pages 24218-24229.
Crossref
Crossref
M Sadeghi, I Lahdou, H Oweira, V Daniel, P Terness, J Schmidt, K-H Weiss, T Longerich, P Schemmer, G Opelz & A Mehrabi. (2015) Serum levels of chemokines CCL4 and CCL5 in cirrhotic patients indicate the presence of hepatocellular carcinoma. British Journal of Cancer 113:5, pages 756-762.
Crossref
Crossref
CHENHONG LUO, KIYOSUMI SHIBATA, SHIRO SUZUKI, HIROAKI KAJIYAMA, TAKESHI SENGA, YOSHIHIRO KOYA, MINA DAIMON, MAMORU YAMASHITA & FUMITAKA KIKKAWA. (2014) GPC3 expression in mouse ovarian cancer induces GPC3-specific T cell-mediated immune response through M1 macrophages and suppresses tumor growth. Oncology Reports 32:3, pages 913-921.
Crossref
Crossref
Andrea F. WiseTimothy M. WilliamsMensiena B. G. KiewietNatalie L. Payne, Christopher SiatskasChrishan S. Samuel & Sharon D. Ricardo. (2014) Human mesenchymal stem cells alter macrophage phenotype and promote regeneration via homing to the kidney following ischemia-reperfusion injury. American Journal of Physiology-Renal Physiology 306:10, pages F1222-F1235.
Crossref
Crossref
Femke Heindryckx. (2014) Targeting the tumor stroma in hepatocellular carcinoma. World Journal of Hepatology 7:2, pages 165.
Crossref
Crossref
Yi-feng He, Mei-ying Zhang, Xin Wu, Xiang-jun Sun, Ting Xu, Qi-zhi He & Wen Di. (2013) High MUC2 Expression in Ovarian Cancer Is Inversely Associated with the M1/M2 Ratio of Tumor-Associated Macrophages and Patient Survival Time. PLoS ONE 8:12, pages e79769.
Crossref
Crossref
Jin Lee & Kye-Taek Lim. (2012) Growth of HepG2 Cells was Suppressed Through Modulation of STAT6/IL-4 and IL-10 in RAW 264.7 Cells Treated by Phytoglycoprotein (38 kDa). Inflammation 36:3, pages 549-560.
Crossref
Crossref
Jin Lee & Kye-Taek Lim. (2012) SJSZ glycoprotein (38 kDa) modulates macrophage type 1/2-related factors at hepatocarcinogenic stage in N-nitrosodiethylamine-treated Balb/c. Molecular and Cellular Biochemistry 372:1-2, pages 17-26.
Crossref
Crossref
Yonghai Li, Donald L Siegel, Nathalie Scholler & David E Kaplan. (2012) Validation of glypican-3-specific scFv isolated from paired display/secretory yeast display library. BMC Biotechnology 12:1.
Crossref
Crossref
Ken Shirabe, Yohei Mano, Jun Muto, Rumi Matono, Takashi Motomura, Takeo Toshima, Kazuki Takeishi, Hidekaki Uchiyama, Tomoharu Yoshizumi, Akinobu Taketomi, Masaru Morita, Shunichi Tsujitani, Yoshihisa Sakaguchi & Yoshihiko Maehara. (2011) Role of tumor-associated macrophages in the progression of hepatocellular carcinoma. Surgery Today 42:1, pages 1-7.
Crossref
Crossref
Rana Chattopadhyay, Patricia de la Vega, Sun H. Paik, Yoko Murata, Earl W. Ferguson, Thomas L. Richie & Guck T. Ooi. (2011) Early Transcriptional Responses of HepG2-A16 Liver Cells to Infection by Plasmodium falciparum Sporozoites. Journal of Biological Chemistry 286:30, pages 26396-26405.
Crossref
Crossref
Yanhui Xu, Hong Li, Rui Lin Gao, Oluwasayo Adeyemo, Maxim Itkin & David E. Kaplan. (2011) Expansion of interferon-gamma-producing multifunctional CD4+ T-cells and dysfunctional CD8+ T-cells by glypican-3 peptide library in hepatocellular carcinoma patients. Clinical Immunology 139:3, pages 302-313.
Crossref
Crossref
Bin Yan, Jing-Jing Wei, Yi-Ming Qian, Xiang-Li Zhao, Wei-Wei Zhang, Ai-Min Xu & Shu-hui Zhang. (2011) Expression and clinicopathologic significance of glypican 3 in hepatocellular carcinoma. Annals of Diagnostic Pathology 15:3, pages 162-169.
Crossref
Crossref
Jun-Wen Yang, Dong-Ye Yang, Fang-Gen Lu, Cai-Hong Li, Hui Chen, Ning Xie & Xin Zhao. (2011) GPC3 fused to an alpha epitope of HBsAg acts as an immune target against hepatocellular carcinoma associated with hepatitis B virus. Hepatobiliary & Pancreatic Diseases International 10:2, pages 164-170.
Crossref
Crossref
Mitchell Ho & Heungnam Kim. (2011) Glypican-3: A new target for cancer immunotherapy. European Journal of Cancer 47:3, pages 333-338.
Crossref
Crossref
James O'Beirne, Farzin Farzaneh & Phillip M Harrison. (2010) Generation of functional CD8+ T Cells by human dendritic cells expressing glypican-3 epitopes. Journal of Experimental & Clinical Cancer Research 29:1.
Crossref
Crossref